Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia

International Journal of Oncology

Volumn 30, Issue 5, 2007, Pages 1069-1075

  Yao, Liang Qing ^a   Feng, You Ji ^a   Ding, Jing Xin ^a   Jing, Hui Ming ^a   Xu, Cong Jian ^a   Chen, Si Feng ^a,b   Su, Ming ^a   Yin, Liang Hua ^a  

^a FUDAN UNIVERSITY   (China)

^b and Clinical Center   (United States)

Author keywords

Epithelial ovarian cancer cells; Hypoxia inducible factor 1 ; Trans differentiation; Vascular endothelial cells like

Indexed keywords

CYCLIN D1; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANOXIA; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANOXIA; CELL DIFFERENTIATION; CYCLIN D1; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34447346001     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.5.1069     Document Type: Article

References (45)

1. Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505-515, 2000. (Pubitemid 30137936)
2. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752, 1999.
3. Folberg R, Hendrix MJC and Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381, 2000.
4. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM and Hendrix MJ: Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50: 189-201, 2002.
5. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, Iwanaga T, Konishi F, Terada M and Wakasugi H: Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 62: 560-566, 2002.
6. Van Rompaey L, Holland E and Grosveld G: TEL induces aggregation in transformed cells and induces tube formation in NIH3T3-UCLA cells. Biochem Biophys Res Commun 291: 820-828, 2002. (Pubitemid 34694349)
7. Bariaga M: New type of blood vessel found in tumors. Science 285: 147, 1999.
8. Hendrix MJC, Seftor EA, Hess AR and Seftor REB: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature 3: 411-421, 2003.
9. Kaufman B, Scharf O, Arbeit J, Ashcroft M, Brown JM, Bruick RK, Chapman JD, Evans SM, Giaccia AJ, Harris AL, Huang E, Johnson R, Kaelin W Jr, Koch CJ, Maxwell P, Mitchell J, Neckers L, Powis G, Rajendran J, Semenza GL, Simons J, Storkebaum E, Welch MJ, Whitelaw M, Melillo G and Ivy SP: Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. Cancer Res 64: 3350-3356, 2004.
10. Kim WJ, Cho H, Lee SW, Kim YJ and Kim KW: Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxiainducible factor-1alpha degradation. Int J Oncol 26: 1049-1052, 2005.
11. Knowles HJ and Harris AL: Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3: 318-322, 2001.
12. Zaffaroni N, Fiorentini G and De Giorgi U: Hyperthermia and hypoxia: new developments in anticancer chemotherapy. Eur J Surg Oncol 27: 340-342, 2001. (Pubitemid 32624533)
13. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB and Klein CE: Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 59: 1578-1573, 1999.
14. Höpfl G, Wenger RH, Ziegler U, Stallmach T, Gardelle O, Achermann R, Wergin M, Kaser-Hotz B, Saunders HM, Williams KJ, Stratford IJ, Gassmann M and Desbaillets I: Rescue of hypoxia-inducible factor-1•-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res 62: 2962-2970, 2002.
15. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000.
16. Jiang Y, Xue ZH, Shen WZ, Du KM, Yan H, Yu Y, Peng ZG, Song MG, Tong JH, Chen Z, Huang Y, Lubbert M and Chen GQ: Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1 alpha that augments transcriptional activity of CCAAT/enhancer-binding protein-alpha. Leukemia 19: 1239-1247, 2005.
17. Jögi A, Ora I and Nilsson H: Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99: 7021-7026, 2002.
18. Helczynska K, Kronblad Á, Jögi A, Nilsson E, Beckman S, Landberg G and Pahlman S: Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 63: 1441-1444, 2003. (Pubitemid 36373625)
19. Yao LQ, Feng YJ, Ding JX, Xu CJ, Jin HY and Yin LH: Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi 40: 662-665, 2005.
20. Van der Schaft DW, Hillen F, Pauwels P, Kirschmann DA, Castermans K, Egbrink MG, Tran MG, Sciot R, Hauben E, Hogendoorn PC, Delattre O, Maxwell PH, Hendrix MJ and Griffioen AW: Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65: 11520-11528, 2005. (Pubitemid 41821710)
21. Sun B, Zhang D, Zhang S, Zhang W, Guo H and Zhao X: Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett, 2006 Sep 22 (Epub ahead of print). (Pubitemid 46452927)
22. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular determination of ovarian cancer plasticity. Am J Pathol 158: 1279-1288, 2001. (Pubitemid 32281292)
23. Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM and Hendrix MJ: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 190: 899-909, 2004. (Pubitemid 38561505)
24. Hendrix MJC, Seftor REB, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD and Schatteman GC: Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62: 665-668, 2002. (Pubitemid 34126938)
25. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J and Langer R: Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 100: 12741-12746, 2003. (Pubitemid 37339969)
26. Thompson SA, Johnson MP, Heidger PM Jr and Lubaroff DM: Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clones. Prostate 6: 369-387, 1985.
27. Nagelkerke JF, Barto KP and van Berkel TJC: In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, kupffer, and parenchymal cells. J Biol Chem 258: 12221-12227, 1983.
28. Brown JM and Giaccia AJ: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416, 1998.
29. Vaupel PW: The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Pediatrics 209: 243-249, 1997.
30. Blancher C, Moore JW, Robertson N and Harris AL: Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res 61: 7349-7355, 2001.
31. Ye F, Chen HZ, Xie X, Ye DF, Lu WG and Ding ZM: Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. Gynecol Oncol 94: 125-133, 2004. (Pubitemid 38950508)
32. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36: 127-137, 1995.
33. Cherrington, JM, Strawn LM and Shawver LK: New paradigms for the treatment of cancer: the role of anti-angiogenesis agents. Adv Cancer Res 79: 1-38, 2000.
34. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N and Zioncheck TF: Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273: 29979-29985, 1998. (Pubitemid 28510016)
35. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS and Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995.
36. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A: Regulation of tumor angiogenesis by p53 induced degradation of hypoxia-inducible factor 1α. Genes Dev 14: 34-44, 2000. (Pubitemid 30051577)
37. Kita Y, Masaki T, Funakoshi F, Yoshida S, Tanaka M, Kurokohchi K, Uchida N, Watanabe S, Matsumoto K and Kuriyama S: Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats. Int J Oncol 24: 1205-1211, 2004.
38. Bos R, van Diest PJ, van der Groep P, Shvarts A, Greijer AE and van der Wall E: Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6: 450-459, 2004.
39. Gehling UM, Leyman ES, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK and Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000.
40. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, More MA and Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD341 cells identifies a population of functional endothelial precursors. Blood 95: 952-959, 2000. (Pubitemid 30062717)
41. Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD and Thorpe PE: Selective inhibition of vascular endothelial growth factor (vegf) receptor 2 (kdr/flk-1) activity by a monoclonal anti-vegf antibody blocks tumor growth in mice. Cancer Res 60: 5117-5124, 2000.
42. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
43. Shmelkov SV, Jun L, McGarrigle D, Derderian CA, Usenko JK, Costa C, Zhang F, Guo X and Rafii S: Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103: 2055-2061, 2004. (Pubitemid 38326220)
44. Asahara T and Kawamoto A: Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579, 2004. (Pubitemid 39095841)
45. +- enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 28: 2070-2073, 2003.